Escin Activates Canonical Wnt/β-Catenin Signaling Pathway by Facilitating the Proteasomal Degradation of Glycogen Synthase Kinase-3β in Cultured Human Dermal Papilla Cells

Abnormal inactivation of the Wnt/β-catenin signaling pathway is involved in skin diseases like androgenetic alopecia, vitiligo and canities, but small-molecule activators are rarely described. In this study, we investigated the stimulatory effects of escin on the canonical Wnt/β-catenin signaling pathway in cultured human dermal papilla cells (hDPCs). Escin stimulated Wnt/β-catenin signaling, resulting in increased β-catenin and lymphoid enhancer-binding factor 1 (LEF1), the accumulation of nuclear β-catenin and the enhanced expression of Wnt target genes in cultured hDPCs. Escin drastically reduced the protein level of glycogen synthase kinase (GSK)-3β, a key regulator of the Wnt/β-catenin signaling pathway, while the presence of the proteasome inhibitor MG-132 fully restored the GSK-3β protein level. The treatment of secreted frizzled-related proteins (sFRPs) 1 and 2 attenuated the activity of escin in Wnt reporter assays. Our data demonstrate that escin is a natural agonist of the canonical Wnt/β-catenin signaling pathway and downregulates GSK-3β protein expression by facilitating the proteasomal degradation of GSK-3β in cultured hDPCs. Our data suggest that escin likely stimulates Wnt signaling through direct interactions with frizzled receptors. This study underscores the therapeutic potential of escin for Wnt-related diseases such as androgenetic alopecia, vitiligo and canities.

[1]  G. Verdine,et al.  Targeted β‐catenin ubiquitination and degradation by multifunctional stapled peptides , 2021, Journal of peptide science : an official publication of the European Peptide Society.

[2]  J. Ji,et al.  Identification of the Role of Wnt/β-Catenin Pathway Through Integrated Analyses and in vivo Experiments in Vitiligo , 2021, Clinical, cosmetic and investigational dermatology.

[3]  S. Guettler,et al.  Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture, phosphorylation, and ubiquitylation , 2021, Molecular cell.

[4]  Youhua Liu,et al.  LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence , 2021, Frontiers in Cell and Developmental Biology.

[5]  J. Nong,et al.  Phase separation of Axin organizes the β-catenin destruction complex , 2021, The Journal of cell biology.

[6]  A. Ransick,et al.  A β-catenin-driven switch in TCF/LEF transcription factor binding to DNA target sites promotes commitment of mammalian nephron progenitor cells , 2021, eLife.

[7]  Ya Zhang,et al.  Targeting the Wnt/β-catenin signaling pathway in cancer , 2020, Journal of Hematology & Oncology.

[8]  Sujuan Xu,et al.  Wnt/β-catenin agonist BIO alleviates cisplatin-induced nephrotoxicity without compromising its efficacy of anti-proliferation in ovarian cancer. , 2020, Life sciences.

[9]  B. Choi.  Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss , 2020, International journal of molecular sciences.

[10]  G. Griebel,et al.  The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents , 2019, Scientific Reports.

[11]  N. Tolwinski,et al.  WNT Signaling in Disease , 2019, Cells.

[12]  X. Ke,et al.  Activating Wnt/&bgr;‐catenin signaling pathway for disease therapy: Challenges and opportunities , 2019, Pharmacology & therapeutics.

[13]  A. Cleton-Jansen,et al.  IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft. , 2018, Cancer letters.

[14]  S. Guettler,et al.  Regulation of Wnt/β‐catenin signalling by tankyrase‐dependent poly(ADP‐ribosyl)ation and scaffolding , 2017, British journal of pharmacology.

[15]  H. Clevers,et al.  Wnt/β-catenin signaling in adult mammalian epithelial stem cells. , 2017, Developmental biology.

[16]  Tor Espen Thorvaldsen.  Targeting Tankyrase to Fight WNT-dependent Tumours. , 2017, Basic & clinical pharmacology & toxicology.

[17]  Dan C. Wilkinson,et al.  Posttranslational modification of β-catenin is associated with pathogenic fibroblastic changes in bronchopulmonary dysplasia. , 2017, American journal of physiology. Lung cellular and molecular physiology.

[18]  J. M. Ceruti,et al.  Androgens modify Wnt agonists/antagonists expression balance in dermal papilla cells preventing hair follicle stem cell differentiation in androgenetic alopecia , 2017, Molecular and Cellular Endocrinology.

[19]  Tian Yang,et al.  Wnt/β-catenin signaling pathway activates melanocyte stem cells in vitro and in vivo. , 2016, Journal of dermatological science.

[20]  Piul S. Rabbani,et al.  EdnrB Governs Regenerative Response of Melanocyte Stem Cells by Crosstalk with Wnt Signaling. , 2016, Cell reports.

[21]  E. Wagner,et al.  Chronic skin inflammation leads to bone loss by IL-17–mediated inhibition of Wnt signaling in osteoblasts , 2016, Science Translational Medicine.

[22]  Jinbang Li,et al.  Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway , 2016, International journal of oncology.

[23]  R. Ballotti,et al.  Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients. , 2015, The Journal of investigative dermatology.

[24]  O. Kim,et al.  IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression , 2015, Oncotarget.

[25]  R. Tollenaar,et al.  The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC , 2014, British Journal of Cancer.

[26]  D. Zheng,et al.  In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators , 2014, Nature Cell Biology.

[27]  K. Ruud,et al.  Analytic density functional theory calculations of pure vibrational hyperpolarizabilities: the first dipole hyperpolarizability of retinal and related molecules. , 2014, The journal of physical chemistry. A.

[28]  C. Moreno,et al.  Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells , 2013, Journal of Translational Medicine.

[29]  N. Eriksson,et al.  Androgenetic alopecia: identification of four genetic risk loci and evidence for the contribution of WNT signaling to its etiology. , 2013, The Journal of investigative dermatology.

[30]  R. Atit,et al.  Epithelial Wnt ligand secretion is required for adult hair follicle growth and regeneration , 2012, The Journal of investigative dermatology.

[31]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[32]  Donald E Ingber,et al.  A Wnt-Bmp Feedback Circuit Controls Intertissue Signaling Dynamics in Tooth Organogenesis , 2012, Science Signaling.

[33]  Piul S. Rabbani,et al.  Coordinated Activation of Wnt in Epithelial and Melanocyte Stem Cells Initiates Pigmented Hair Regeneration , 2011, Cell.

[34]  Dianqing Wu,et al.  GSK3: a multifaceted kinase in Wnt signaling. , 2010, Trends in biochemical sciences.

[35]  Marc W. Kirschner,et al.  Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling , 2009, Nature.

[36]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[37]  Slava Ziegler,et al.  Chronological expression of Wnt target genes Ccnd1, Myc, Cdkn1a, Tfrc, Plf1 and Ramp3 , 2009, Cell biology international.

[38]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[39]  Yusuke Nakamura,et al.  DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway , 2004, Oncogene.

[40]  J Mao,et al.  Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. , 2001, Molecular cell.

[41]  Hideki Yamamoto,et al.  Phosphorylation of Axin, a Wnt Signal Negative Regulator, by Glycogen Synthase Kinase-3β Regulates Its Stability* , 1999, The Journal of Biological Chemistry.

[42]  Jörg Stappert,et al.  β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .

[43]  Paul Polakis,et al.  Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.

[44]  W. Weis,et al.  The β-catenin destruction complex. , 2013, Cold Spring Harbor perspectives in biology.

[45]  P. Greengard,et al.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.